Clinical Trials in Atlanta

Showing 15101-15120 of 19,805 trials

Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

NCT00006010

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of gemcitabine plus docetaxel in treating patients who have unresectable or metastatic liver cancer.

Liver Cancer

Alliance for Clinical Trials in Oncology25 participantsStarted Sep 2001

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Atlanta, Georgia, United States +14 more locations

COMPLETEDPhase 2< 1 mile

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders

NCT02120300

The primary objectives of this study are to evaluate the antiviral efficacy, safety, and tolerability of treatment with ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) in participants with genotypes 1 and 4 hepatitis C virus (HCV) infection and sofosbuvir (SOF) plus ribavirin (RBV) in participants with genotypes 2 and 3 HCV infection. Participants with an inherited bleeding disorder and chronic HCV infection (either monoinfected or HIV-1/HCV coinfected) will be enrolled.

Chronic HCV Infection

Gilead Sciences122 participantsStarted Apr 2014

Sacramento, California, United States • San Diego, California, United States • San Francisco, California, United States +10 more locations

Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders

Find Trials by Condition in Atlanta

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

Ixabepilone + Carboplatin Metastatic Breast Cancer

Safety of Rt-PA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery

Stimulant Abuser Groups to Engage in 12-Step

Effectiveness of Lumbar Fusion When NanOss Bioactive Is Used With Posterolateral Gutter Fusions

Using Stories to Address Disparities in Hypertension

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C

Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects